Tomaio L Pseudomonas fluorescens
Classification
Genus species Pseudomonas lini Scientific classification Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gamma Proteobacteria
Order: Pseudomonadales
Family: Pseudomonadaceae
Species
Genus: Pseudomonas
Species: Pseudomonas Fluorescens
Habitat Information
Date of collection: 1/27/15
Location: 6636 W. William cannon Dr. Austin, TX 78735
Lat/:on: 30.27N 97.74W (Elev. 508ft)
Air Temperature: 80 degrees F
Humidity: 23%
24 hr rainfall: 0
Solar Radiation: 12.84
Description and Significance
Colonial Morphology:
Color:white
Elevation:Convex
Margin:Smooth
Cell Morphology:
Members of the genus display these defining characteristics:
* Rod-shaped
* Gram-negative
*One or more polar flagella, providing motility
* Aerobic
* Nonspore-forming
Test Results
* Negative catalase test (this result is questionable) * Negative oxidase test (this result is questionable)
* Positive EMB for G- growth * Positive EMB for lactose fermentation * Positive MAC for G- growth * Positive HE for G- growth * Positive arganine decarboxylation test * Positive Blood Agar test
Antimicrobial activity :
Most Psuedomonas species are penicillin resistant, so other choices for treatment might include Ciprofloxacin, ticarcillin, imipenem or piperacillin. This resistance is due to their cell walls which contain prions. [1]
.
Pseudomonas aeruginosa is increasingly recognized as an emerging opportunistic pathogen of clinical relevance. One of its most worrying characteristics is its low antibiotic susceptibility.[18] This low susceptibility is attributable to a concerted action of multidrug efflux pumps with chromosomally encoded antibiotic resistance genes (e.g., mexAB-oprM, mexXY, etc.,[19]) and the low permeability of the bacterial cellular envelopes. Besides intrinsic resistance, P. aeruginosa easily develops acquired resistance either by mutation in chromosomally encoded genes or by the horizontal gene transfer of antibiotic resistance determinants. Development of multidrug resistance by P. aeruginosa isolates requires several different genetic events that include acquisition of different mutations and/or horizontal transfer of antibiotic resistance genes. Hypermutation favours the selection of mutation-driven antibiotic resistance in P. aeruginosa strains producing chronic infections, whereas the clustering of several different antibiotic resistance genes in integrons favours the concerted acquisition of antibiotic resistance determinants. Some recent studies have shown phenotypic resistance associated to biofilm formation or to the emergence of small-colony-variants may be important in the response of P. aeruginosa populations to antibiotic treatment.
Ceftazidine proved very effective as did clove and tea tree in sensitivity testing.
Genome Structure
Describe the size and content of the genome. How many chromosomes? Circular or linear? Other interesting features? What is known about its sequence? Include S Ribosomal sequence that you obtained from PCR and sequencing here.
Pseudomonas fluorescens Strain DH-27 16S Ribosomal
Max score: 1291 Total score: 1291 Query Cover: 100% E Value: 0.0 Ident: 99% Accession: KF646699.1
Cell Structure, Metabolism and Life Cycle
Pseudomonas fluorescens produces phloroglucinol, phloroglucinol carboxylic acid and diacetylphloroglucinol. Biodegradation capacities
4-Hydroxyacetophenone monooxygenase is an enzyme found in P. fluorescens that transform piceol, NADPH, H+ and O2 into 4-hydroxyphenyl acetate, NADP+ and H2O.
Physiology and Pathogenesis
Pseudomonas fluorescens may be useful in protecting plants from fungus and nemotade attacks.
By culturing Pseudomonas fluorescens, Mupirocin (an antibiotic) can be produced, which has been found to be useful in treating skin, ear, and eye disorders.[19] Mupirocin free acid and its salts and esters are agents currently used in creams, ointments, and sprays as a treatment of Methicillin-resistant Staphylococcus aureus (MRSA) infection.
P. fluorescens demonstrates hemolytic activity and, as a result, has been known to infect blood transfusions.
It is also used in milk to make yogurt.
Disease:
P. fluorescens is an unusual cause of disease in humans, and usually affects patients with compromised immune systems (e.g., patients on cancer treatment). From 2004 to 2006, there was an outbreak of P. fluorescens in the United States, involving 80 patients in six states. The source of the infection was contaminated heparinized saline flushes being used with cancer patients.
Medical Properties: By culturing Pseudomonas fluorescens, Mupirocin (an antibiotic) can be produced, which has been found to be useful in treating skin, ear, and eye disorders. Mupirocin free acid and its salts and esters are agents currently used in creams, ointments, and sprays as a treatment of Methicillin-resistant Staphylococcus aureus (MRSA) infection.
P. fluorescens demonstrates hemolytic activity and, as a result, has been known to infect blood transfusions.
It is also used in milk to make yogurt.
United States Patents: 6489358, 4873012, 6156792
References
1. http://en.m.wikipedia.org/wiki/Pseudomonas
2. http://en.wikipedia.org/wiki/Pseudomonas_fluorescens
Author
Page authored by Louisa Tomaio, student of Prof. Kristine Hollingsworth at Austin Community College.